Brief: Protagonist Therapeutics - Net Loss Was $0.69 Per Share, For Q4 2022

Protagonist Therapeutics

15/03/2023 20:51

March 15 (Reuters) - Protagonist Therapeutics Inc
 PTGX.O :
    * PROTAGONIST THERAPEUTICS - NET LOSS WAS $0.69 PER SHARE,
FOR Q4
2022
    * PROTAGONIST THERAPEUTICS - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES AS OF DECEMBER 31, 2022 WERE $237.4 MILLION
    * Q1 EARNINGS PER SHARE VIEW $-0.69 -- REFINITIV IBES DATA

Source text: [ID:https://m5.gs/Yzh3Z0]
Further company coverage:  PTGX.O 

 ((Reuters.Briefs@thomsonreuters.com;))